Sekisui Diagnostics LLC  

Lexington,  MA 
United States
http://www.sekisuidiagnostics.com
  • Booth: 2438

Booth Profile

Headquartered in Lexington, MA, for over 30 years Sekisui Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. Sekisui Diagnostic’s workforce includes over 500 employees, in six sites located in four countries. We are a sister company to Sekisui Medical in Japan and in China, making us a worldwide company with R&D and Manufacturing facilities on three continents. We develop, manufacture, and supply over 1.7 billion tests each year to the global healthcare market through our commercial networks and partners. Our product lines include: • Clinical chemistry systems and reagents • Coagulation systems and reagents • Rapid tests, immunoassay and molecular point of care test systems • Enzymes and specialty biochemicals


 Products

  • Silaris™ Influenza A&B Test
    The CLIA Waived Silaris™ Influenza A&B Test is a unique molecular diagnostic test that offers the simplicity, convenience and procedural familiarity of traditional visual read rapid tests, while providing the superior sensitivity and specificity of laboratory‐based PCR testing for early diagnosis and proper management of influenza....
             

  • Silaris™ is a unique molecular diagnostic test that offers the simplicity, convenience and procedural familiarity of traditional visual read rapid tests, while providing the superior sensitivity and specificity of true laboratory‐based PCR testing for point‐of‐care (POC) infectious disease diagnosis. The system utilizes proprietary OscAR™ technology within a state-of-the art microfluidic cassette allowing facilities to implement an affordable, high performing, CLIA Waived, molecular testing option to diagnose and treat patients quickly and effectively. The platform is cleared for the detection of the influenza A and B virus, showing a sensitivity of 97% for Flu A and 94% for Flu B.  For more information, visit www.silaris.com.

  • SEKURE® HbA1c Assay
    The SEKURE® HbA1c assay is an enzymatic assay which is NGSP certified and utilizes an onboard pretreatment step on Sekisui Diagnostics SKTM500 Clinical Chemistry System, eliminating time-consuming manual preparation prior to testing....
     

  • The SEKURE® HbA1c assay is used in clinical laboratories to measure the percent concentration of HbA1c (NGSP) or the HbA1c fraction mmol/mol (IFCC) in human venous whole blood and hemolysate.  It is an enzymatic assay which is NGSP certified and utilizes an onboard pretreatment step on Sekisui Diagnostics SKTM500 Clinical Chemistry System, eliminating time-consuming manual preparation prior to testing.  With the FDA clearance, the SEKURE® HbA1c test is now available on the SK500 in both the US as well as the European Union as it previously obtained a CE mark.


 Additional Info

Included in the Export Interest Directory?
No
Business Needs:
Direct Sales, Distributor/Agent/Representative